NTLA
#2066
Intellia Therapeutics, Inc. - Common Stock
13.0 2 USD
-0.08%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-8.44%
Monthly Change
+2.52%
6 month change
+25.19%
Year Change
-5.10%
Previous Close
14.2 2
Open
13.0 2
Low
13.0 2
High
13.0 2
Volume
117
Financials
- Market Capitalization 1.82 B
- Employee 377
- Founded 2014
- CEO John Leonard
- Website www.intelliatx.com
- Headquarter Delaware, United States
- FIGI BBG007KC7PB0
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.36
Price to sales ratio
14.4
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2059 |  ATAI AtaiBeckley Inc. - Common Stock | 4.97 USD | -3.87% | -1.00% | +30.45% | +25.82% | 1.83 B USD | ||
| 2065 |  ZYME Zymeworks Inc. - Common Stock | 24.94 USD | -3.63% | -1.81% | +8.34% | +40.59% | 1.82 B USD | ||
| 2069 |  IOVA Iovance Biotherapeutics, Inc. - Common Stock | 4.04 USD | -4.49% | -4.94% | +2.02% | +106.12% | 1.80 B USD | ||
| 2088 |  ZBIO Zenas BioPharma, Inc. - Common Stock | 27.88 USD | -2.99% | +5.25% | +56.81% | +5.37% | 1.76 B USD |
Frequently asked questions about Intellia Therapeutics, Inc. - Common Stock
What is the Intellia Therapeutics, Inc. - Common Stock stock price today?
The current price of Intellia Therapeutics, Inc. - Common Stock (NTLA) is 13.02. Over the past 24 hours, the stock has changed by -8.44%. Follow the NTLA chart for real-time price dynamics.
What is the stock ticker of Intellia Therapeutics, Inc. - Common Stock?
Intellia Therapeutics, Inc. - Common Stock trades under the ticker NTLA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Intellia Therapeutics, Inc. - Common Stock stock going up?
NTLA has changed by -27.06% over the last week, +2.52% over the last month, and -5.10% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Intellia Therapeutics, Inc. - Common Stock net income for the last quarter?
Intellia Therapeutics, Inc. - Common Stock reported net income of -96.23 M for the last quarter. The previous quarter showed -95.79 M, which means net income changed by -0.46%.
How many employees does Intellia Therapeutics, Inc. - Common Stock have?
As of the latest available data, Intellia Therapeutics, Inc. - Common Stock has 377 employees. Workforce size can provide additional context about the company's scale and operations.
What is Intellia Therapeutics, Inc. - Common Stock EBITDA?
Intellia Therapeutics, Inc. - Common Stock EBITDA is -98.33 M, and its EBITDA margin is -653.44%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Intellia Therapeutics, Inc. - Common Stock stock?
You can buy Intellia Therapeutics, Inc. - Common Stock (NTLA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Intellia Therapeutics, Inc. - Common Stock stock?
Investing in Intellia Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NTLA chart and related analysis on metatrader.com as part of your research.